Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hawley C Pruitt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncogenesis|June 3, 2021
Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumorsHeba Allah M Alsheikh, Brandon J Metge, Hawley C Pruitt, et al.
Scientific Reports|October 28, 2017
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer ModelKayla F Goliwas, Jillian R Richter, Hawley C Pruitt, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 18, 2023
Collagen VI deposition mediates stromal T cell trapping through inhibition of T cell motility in the prostate tumor microenvironmentHawley C Pruitt, Ya Guan, Hudson Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 11, 2019
Engineering an Artificial T-Cell Stimulating Matrix for ImmunotherapyJohn W Hickey, Yi Dong, Jae Wook Chung, et al.
Molecular Cancer|September 2, 2014
microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancerJack W Rostas, Hawley C Pruitt, Brandon J Metge, et al.
Nature Communications|October 14, 2022
Nanoparticle-based modulation of CD4<sup>+</sup> T cell effector and helper functions enhances adoptive immunotherapyAriel Isser, Aliyah B Silver, Hawley C Pruitt, et al.
The Journal of Clinical Investigation|April 23, 2024
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironmentAshley M Fuller, Hawley C Pruitt, Ying Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncogenesis|June 3, 2021
Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumorsHeba Allah M Alsheikh, Brandon J Metge, Hawley C Pruitt, et al.
Scientific Reports|October 28, 2017
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer ModelKayla F Goliwas, Jillian R Richter, Hawley C Pruitt, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 18, 2023
Collagen VI deposition mediates stromal T cell trapping through inhibition of T cell motility in the prostate tumor microenvironmentHawley C Pruitt, Ya Guan, Hudson Liu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 11, 2019
Engineering an Artificial T-Cell Stimulating Matrix for ImmunotherapyJohn W Hickey, Yi Dong, Jae Wook Chung, et al.
Molecular Cancer|September 2, 2014
microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancerJack W Rostas, Hawley C Pruitt, Brandon J Metge, et al.
Nature Communications|October 14, 2022
Nanoparticle-based modulation of CD4<sup>+</sup> T cell effector and helper functions enhances adoptive immunotherapyAriel Isser, Aliyah B Silver, Hawley C Pruitt, et al.
The Journal of Clinical Investigation|April 23, 2024
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironmentAshley M Fuller, Hawley C Pruitt, Ying Liu, et al.
Pageof 2